Health care stocks gained Wednesday afternoon, with the NYSE Health Care Index up 0.4% and the Health Care Select Sector SPDR Fund (XLV) adding 0.5%.
The iShares Biotechnology ETF (IBB) increased 0.4%.
In corporate news, Trinity Biotech (TRIB) shares jumped about 28% after it said Wednesday that it has received regulatory approval to begin offshore and outsourced manufacturing of its TrinScreen HIV rapid test.
Tharimmune (THAR) shares surged 103% after it said Wednesday that results from an analysis of its lead drug candidate TH104 showed that it could potentially be used as a countermeasure for military personnel and chemical incident responders exposed to high-potency opioids, including weaponized fentanyl.
CVS Health's (CVS) Caremark unit has been ordered to pay about $289.9 million in a whistleblower case involving Medicare fraud claims, according to a court ruling on Tuesday. CVS shares increased 0.2%.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。